Our Story

Who we are

Carbogenics is an award-winning cleantech company based in Edinburgh. We produce functional bio-additives from organic waste such as secondary biomass and difficult to recycle paper waste. Our first patent-pending flagship product CreChar® enhances anaerobic digestion and wastewater treatment, and can also be used for soil amendment and carbon sequestration.
 
Founded in 2016, Carbogenics has grown to ten staff at its University of Edinburgh base, where it has access to world-class research and testing facilities through the University and its industrial partners. As the global issues of energy and food sustainability and security grow in importance, Carbogenics intends to play a key role in enabling a Net Zero Scotland and world.
Carbogenics Team Members

Carbogenics was spun out of the University of Edinburgh in April 2016.

It was founded by then Marie Curie Researcher Dr Jan Mumme and PhD student Franziska Srocke. Jan, an agricultural engineer, and Franziska, a biotechnical engineer, both worked at the UK Biochar Research Centre at the University’s School of GeoSciences where they discovered the potential of biochar as an amendment for soil and biogas production. A few months, later the founders were joined by Lidia Krzynowek, a social geographer who was working at Napier University where she supported startups in the area of biofuels.

The invention of Jan and Franziska of CreChar, a novel type of biochar that boosts biogas production, led to a patent application and several R&D grants and awards including from Scottish Enterprise, Converge, EDGE, IBioIC and IUK. A first investment round was completed in 2018, a second in 2019.

Our vision and values

Our vision is to become THE leading provider of sustainable bio-additives designed for the anaerobic digestion and wastewater treatment industries. Through the application of circular processes and our carbon-negative technology, we will become a global leader in carbon upcycling and a key player in the circular economy enabling energy security and sustainability.

Our approach to business is guided by a set of six core values:

CreChar®

Our journey so far

2025
Launch of Carbogenics USA!
2024
Expanded full scale industrial trials to further evidence CreChar
2024
Secured £400,000 of investment to progress global growth
2024
We opened our first post-processing production facility in Glenrothes Scotland
2024
Carbogenics Secures 2nd Innovate UK Grant to develop EcoChar!
2024
Carbogenics Secures Innovate UK Grant in Collaboration with Scottish Water to develop FilaChar
2024
We won the Scottish Life Science's Award for Sustainability through our work on CreChar® and FilaChar® products
2023
Raised more than £1m in investment to build our first production and R&D facility
2022
2021
First full scale industrial trial

2021
First full-scale commercial production and testing of CreChar®

2021
Strategic reorganisation and appointment of new CEO - Professor Ed Craig

2020
Team grows from four to eight members

2019
Second round of seed investment is concluded

2019
CreChar® wins the Scottish EDGE competition

2018
First round of seed investment is concluded

2018
Our innovative carbon product CreChar® wins the Converge Challenge

2017
The patent application for our flagship product CreChar® is filed

2016
Carbogenics is founded as a spin-out company from the University of Edinburgh
2025
  • Launch of Carbogenics USA!

  • Launch of Carbogenics Series A funding round for £4 million

  • Carbogenics takes on first USA staff member - based in new Mexico
2024
  • We won the Scottish Life Science's Award for Sustainability through our work on CreChar® and FilaChar® products

  • Carbogenics Secures Innovate UK Grant in Collaboration with Scottish Water to develop FilaChar

  • Carbogenics Secures 2nd Innovate UK Grant to develop EcoChar!

  • We opened our first post-processing production facility in Glenrothes Scotland

  • Secured £400,000 extension to seed round to progress global growth!

  • Secured a Scottish Enterprise Grant to explore additional CreChar impacts on AD operation

  • Expanded full scale industrial trials to further evidence CreChar - secured 5 new trials
2023
  • Raised more than £1m in investment to build our first production and R&D facility

  • Advanced PIiot-scale Validation & Market Expansion

  • Introduced paid trials to validate commercial value

  • Team expands to 10!
2021
  • Strategic reorganisation and appointment of new CEO - Professor Ed Craig

  • First full scale industrial trial

  • Market engagement

  • Market strategy and positioning
2020
  • Team grows from four to eight members

  • Initiated full scale trials in 4 AD Plants

  • Optimised dosing, resolved trial challenges and discovered more benefits

  • Supply chain development
2019
  • Began advanced lab trials

  • CreChar® wins the Scottish EDGE competition

  • Second round of seed investment is concluded
2018
  • Developed product concept

  • Patented product after successful lab tests

  • Our innovative carbon product CreChar® wins the Converge Challenge

  • First round of seed investment is concluded
2017
The patent application for our flagship product CreChar® is filed

2016
Carbogenics is founded as a spin-out company from the University of Edinburgh